C5 and viral infectious disease: By inhibiting complement activation or amplification, viruses can suppress the production of complement-derived anaphylatoxins (C3a and C5a) and potentially interfere with their signaling pathways, thereby attenuating local inflammatory responses and suppressing extravasation of immune cells to sites of viral infection [29].